{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:51:19Z","timestamp":1790189479511,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008593","name":"European Respiratory Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ajpath.2019.02.007","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T15:14:03Z","timestamp":1553613243000},"page":"1159-1175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease"],"prefix":"10.1016","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8388-6131","authenticated-orcid":false,"given":"Sven","family":"G\u00fcnther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Perros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Emmanuel","family":"Rautou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Girerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5996-665X","authenticated-orcid":false,"given":"Maria-Rosa","family":"Ghigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7180-6242","authenticated-orcid":false,"given":"Dominique","family":"Cazals-Hatem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund M.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dorfm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Sitbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique C.","family":"Valla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-6922","authenticated-orcid":false,"given":"David","family":"Montani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2019.02.007_bib1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ajpath.2019.02.007_bib2","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/0016-5085(80)90911-7","article-title":"An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation","volume":"79","author":"Shulman","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2019.02.007_bib3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.ajpath.2019.02.007_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors","volume":"4","author":"McDonald","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2019.02.007_bib5","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.bbmt.2011.06.006","article-title":"The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade","volume":"17","author":"Carreras","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ajpath.2019.02.007_bib6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.clinre.2016.01.006","article-title":"Sinusoidal obstruction syndrome","volume":"40","author":"Valla","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/SLA.0b013e3182a6183e","article-title":"Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival","volume":"258","author":"Vigan\u00f2","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.ajpath.2019.02.007_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4065\/78.5.589","article-title":"Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation","volume":"78","author":"Kumar","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ajpath.2019.02.007_bib9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/bmt.2015.52","article-title":"Sinusoidal obstruction syndrome\/veno-occlusive disease: current situation and perspectives: a position statement from the European Society for Blood and Marrow Transplantation (EBMT)","volume":"50","author":"Mohty","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ajpath.2019.02.007_bib10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0030-4220(91)90552-N","article-title":"Oral mucositis after bone marrow transplantation: a marker of treatment toxicity and predictor of hepatic veno-occlusive disease","volume":"72","author":"Wingard","year":"1991","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib11","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jceh.2014.10.002","article-title":"Sinusoidal obstruction syndrome (hepatic veno-occlusive disease)","volume":"4","author":"Fan","year":"2014","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2217\/ijh-2017-0015","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome with multiorgan failure","volume":"6","author":"Richardson","year":"2017","journal-title":"Int J Hematol Oncol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib13","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2011.65","article-title":"The role of the endothelium in the short-term complications of hematopoietic SCT","volume":"46","author":"Carreras","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ajpath.2019.02.007_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","article-title":"Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease)","volume":"22","author":"DeLeve","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ajpath.2019.02.007_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jhep.2013.04.014","article-title":"Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model","volume":"59","author":"Robinson","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib16","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/hep.27747","article-title":"The significance of nonobstructive sinusoidal dilatation of the liver: impaired portal perfusion or inflammatory reaction syndrome","volume":"62","author":"Marzano","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2019.02.007_bib17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1055\/s-0035-1556728","article-title":"Interplay of inflammation and endothelial dysfunction in bone marrow transplantation: focus on hepatic veno-occlusive disease","volume":"41","author":"Vion","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ajpath.2019.02.007_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1365-2559.1999.00569.x","article-title":"Hepatic stellate cells (Ito cells) in veno-occlusive disease of the liver after allogeneic bone marrow transplantation","volume":"34","author":"Sato","year":"1999","journal-title":"Histopathology"},{"key":"10.1016\/j.ajpath.2019.02.007_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s002770050364","article-title":"Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications","volume":"76","author":"N\u00fcrnberger","year":"1998","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.bmt.1700767","article-title":"Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease","volume":"19","author":"Salat","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ajpath.2019.02.007_bib21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1148\/radiol.10100025","article-title":"Radiologic imaging and intervention for gastrointestinal and hepatic complications of hematopoietic stem cell transplantation","volume":"258","author":"Mahgerefteh","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.ajpath.2019.02.007_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1148\/radiology.204.2.9240551","article-title":"Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients","volume":"204","author":"Lassau","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.ajpath.2019.02.007_bib23","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2214\/ajr.154.4.2107664","article-title":"Doppler sonography: a noninvasive method for evaluation of hepatic venocclusive disease","volume":"154","author":"Brown","year":"1990","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib24","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2214\/AJR.05.0539","article-title":"CT features of hepatic venoocclusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transplantation","volume":"186","author":"Erturk","year":"2006","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib25","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1200\/JCO.2008.16.1893","article-title":"Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxide-enhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases","volume":"26","author":"Ward","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib26","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ejso.2009.01.015","article-title":"Accuracy of liver-specific magnetic resonance imaging as a predictor of chemotherapy-associated hepatic cellular injury prior to liver resection","volume":"35","author":"O'Rourke","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib27","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/hep.27132","article-title":"Diagnosis of sinusoidal obstruction syndrome by positron emission tomography\/computed tomography: report of two cases treated by defibrotide","volume":"60","author":"Gauth\u00e9","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2019.02.007_bib28","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1007\/s00330-017-5179-z","article-title":"Noninvasive assessment of hepatic sinusoidal obstructive syndrome using acoustic radiation force impulse elastography imaging: a proof-of-concept study in rat models","volume":"28","author":"Park","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bmt.2012.113","article-title":"Non-invasive transient elastography for the prediction of liver toxicity following hematopoietic SCT","volume":"48","author":"Auberger","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ajpath.2019.02.007_bib30","first-page":"21","article-title":"Transjugular liver biopsy in BMT","volume":"11","author":"Carreras","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ajpath.2019.02.007_bib31","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/00007890-199504150-00017","article-title":"Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients","volume":"59","author":"Shulman","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.ajpath.2019.02.007_bib32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00270-013-0672-5","article-title":"Diagnostic yield of transjugular liver biopsy samples to evaluate for infectious etiology of liver dysfunction in bone marrow transplant recipients","volume":"37","author":"Nadolski","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jvir.2016.01.007","article-title":"Assessing the risk of hemorrhagic complication following transjugular liver biopsy in bone marrow transplantation recipients","volume":"27","author":"Ahmed","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/bjh.13215","article-title":"How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation","volume":"168","author":"Carreras","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib35","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00000421-199212000-00008","article-title":"Nonbacterial thrombotic endocarditis clinically mimicking veno-occlusive disease of the liver complicating autologous bone marrow transplantation","volume":"15","author":"Vukelja","year":"1992","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib36","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2003-11-3778","article-title":"Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation","volume":"104","author":"Srivastava","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2019.02.007_bib37","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bmt.1704943","article-title":"The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation","volume":"35","author":"Kallianpur","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ajpath.2019.02.007_bib38","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0022-3476(76)80988-2","article-title":"Familial hepatic venoocclusive disease with probable immune deficiency","volume":"88","author":"Mellis","year":"1976","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajpath.2019.02.007_bib39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.clim.2012.07.016","article-title":"Hepatic veno-occlusive disease with immunodeficiency (VODI): first reported case in the U.S. and identification of a unique mutation in Sp110","volume":"145","author":"Wang","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib40","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jaci.2012.02.054","article-title":"Clinical, molecular, and cellular immunologic findings in patients with SP110-associated veno-occlusive disease with immunodeficiency syndrome","volume":"130","author":"Cliffe","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib41","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ng1780","article-title":"Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease","volume":"38","author":"Roscioli","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2019.02.007_bib42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajpath.2019.02.007_bib43","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/hep.22772","article-title":"Vascular disorders of the liver","volume":"49","author":"DeLeve","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2019.02.007_bib44","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2019.02.007_bib45","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ajpath.2014.10.021","article-title":"Chemotherapy-induced pulmonary hypertension: role of alkylating agents","volume":"185","author":"Ranchoux","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib46","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/gut.17.11.849","article-title":"Study of an epidemic of venoocclusive disease in India","volume":"17","author":"Tandon","year":"1976","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2019.02.007_bib47","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/bjh.12558","article-title":"BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation","volume":"163","author":"Dignan","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib48","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbmt.2013.10.014","article-title":"Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study","volume":"20","author":"Ruutu","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ajpath.2019.02.007_bib49","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","article-title":"Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation","volume":"100","author":"Ruutu","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2019.02.007_bib50","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1182\/blood-2015-10-676924","article-title":"Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure","volume":"127","author":"Richardson","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2019.02.007_bib51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bmt.1705896","article-title":"Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course of methylprednisolone","volume":"41","author":"Al Beihany","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ajpath.2019.02.007_bib52","first-page":"3599","article-title":"Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2019.02.007_bib53","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.510290615","article-title":"Characterization of a reproducible rat model of hepatic veno-occlusive disease","volume":"29","author":"DeLeve","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2019.02.007_bib54","first-page":"446","article-title":"Experimental model of hepatic venoocclusive disease (VOD) caused by dactinomycin: preliminary report about hepatoprotective effect of amifostine","volume":"6","author":"Czauderna","year":"2000","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ajpath.2019.02.007_bib55","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ajpath.2019.02.007_bib56","first-page":"100","article-title":"[On the histology of clinical primary pulmonary sclerosis]","volume":"47","author":"H\u00f6ra","year":"1934","journal-title":"German. Frankf Z Pathol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib57","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/01.CIR.34.2.242","article-title":"Pulmonary veno-occlusive disease","volume":"34","author":"Heath","year":"1966","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2019.02.007_bib58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ng.2844","article-title":"EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension","volume":"46","author":"Eyries","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2019.02.007_bib59","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1378\/chest.13-2366","article-title":"EIF2AK4 mutations in pulmonary capillary hemangiomatosis","volume":"145","author":"Best","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.ajpath.2019.02.007_bib60","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1183\/13993003.00026-2016","article-title":"Pulmonary veno-occlusive disease","volume":"47","author":"Montani","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ajpath.2019.02.007_bib61","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/CIRCULATIONAHA.115.014207","article-title":"Mitomycin-induced pulmonary veno-occlusive disease: evidence from human disease and animal models","volume":"132","author":"Perros","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2019.02.007_bib62","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00002018-200022040-00002","article-title":"Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention","volume":"22","author":"Pai","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.ajpath.2019.02.007_bib63","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1183\/13993003.00814-2015","article-title":"Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease","volume":"46","author":"Montani","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ajpath.2019.02.007_bib64","doi-asserted-by":"crossref","first-page":"D51","DOI":"10.1016\/j.jacc.2013.10.023","article-title":"Pulmonary arterial hypertension: epidemiology and registries","volume":"62","author":"McGoon","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib65","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1164\/rccm.201205-0886OC","article-title":"Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension","volume":"186","author":"Larkin","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajpath.2019.02.007_bib66","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1177\/0960327113477874","article-title":"The effects of gender difference on monocrotaline-induced pulmonary hypertension in rats","volume":"32","author":"Bal","year":"2013","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib67","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1164\/rccm.201208-1364OC","article-title":"Cytotoxic cells and granulysin in pulmonary arterial hypertension and pulmonary veno-occlusive disease","volume":"187","author":"Perros","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajpath.2019.02.007_bib68","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.RES.0000126847.27660.69","article-title":"Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension","volume":"94","author":"Marcos","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2019.02.007_bib69","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.yexmp.2005.08.010","article-title":"Endothelial nitric oxide synthase expression in pulmonary capillary hemangiomatosis","volume":"79","author":"Kradin","year":"2005","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib70","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.healun.2017.09.022","article-title":"Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease","volume":"37","author":"Nossent","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ajpath.2019.02.007_bib71","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01230858","article-title":"The pathology of pulmonary veno-occlusive disease","volume":"364","author":"Wagenvoort","year":"1974","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib72","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1183\/09031936.96.09020346","article-title":"Human alveolar capillaries undergo angiogenesis in pulmonary veno-occlusive disease","volume":"9","author":"Schraufnagel","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ajpath.2019.02.007_bib73","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MD.0b013e31818193bb","article-title":"Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology","volume":"87","author":"Montani","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ajpath.2019.02.007_bib74","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2213-2600(16)30438-6","article-title":"Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study","volume":"5","author":"Montani","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ajpath.2019.02.007_bib75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2214\/ajr.183.1.1830065","article-title":"Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease","volume":"183","author":"Resten","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib76","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1183\/09031936.06.00054105","article-title":"Occult alveolar haemorrhage in pulmonary veno-occlusive disease","volume":"27","author":"Rabiller","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ajpath.2019.02.007_bib77","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/1753465812468042","article-title":"A case of pulmonary veno-occlusive disease: diagnostic dilemmas and therapeutic challenges","volume":"7","author":"Sourla","year":"2013","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.ajpath.2019.02.007_bib78","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1183\/13993003.00717-2015","article-title":"Genetic counselling in a national referral centre for pulmonary hypertension","volume":"47","author":"Girerd","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ajpath.2019.02.007_bib79","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1183\/09031936.00106008","article-title":"Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy","volume":"34","author":"Overbeek","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ajpath.2019.02.007_bib80","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.humpath.2006.11.022","article-title":"Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases","volume":"38","author":"Dorfm\u00fcller","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib81","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.88.5.2149","article-title":"Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults","volume":"88","author":"Celermajer","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2019.02.007_bib82","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3109\/01902149109064331","article-title":"Effect of long-term cigarette smoke exposure on pulmonary vascular structure and function in the guinea pig","volume":"17","author":"Wright","year":"1991","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.ajpath.2019.02.007_bib83","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4103\/2045-8932.105027","article-title":"Smoking: is it a risk factor for pulmonary vascular diseases?","volume":"2","author":"Weissmann","year":"2012","journal-title":"Pulm Circ"},{"key":"10.1016\/j.ajpath.2019.02.007_bib84","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/ajhp\/54.7.787","article-title":"Amifostine for protection from antineoplastic drug toxicity","volume":"54","author":"Foster-Nora","year":"1997","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ajpath.2019.02.007_bib85","first-page":"1671","article-title":"Pulmonary veno-occlusive disease: a case series and new observations","volume":"118","author":"Holcomb","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.ajpath.2019.02.007_bib86","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0026-2862(89)90017-4","article-title":"Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline-treated rats","volume":"38","author":"Wilson","year":"1989","journal-title":"Microvasc Res"},{"key":"10.1016\/j.ajpath.2019.02.007_bib87","first-page":"84","article-title":"Crotalaria-induced pulmonary hypertension: uptake of 3H-thymidine by the cells of the pulmonary circulation and alveolar walls","volume":"106","author":"Meyrick","year":"1982","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib88","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0169-5002(01)00479-2","article-title":"Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma","volume":"36","author":"Gagnadoux","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ajpath.2019.02.007_bib89","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1183\/09031936.93.06040596","article-title":"Pulmonary veno-occlusive disease and Hodgkin's lymphoma","volume":"6","author":"Swift","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ajpath.2019.02.007_bib90","first-page":"636","article-title":"Pulmonary veno-occlusive disease due to bleomycin therapy for lymphoma: case reports","volume":"64","author":"Rose","year":"1983","journal-title":"S Afr Med J"},{"key":"10.1016\/j.ajpath.2019.02.007_bib91","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0006-2952(95)02189-2","article-title":"Effects of monocrotaline, a pyrrolizidine alkaloid, on glutathione metabolism in the rat","volume":"51","author":"Yan","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib92","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/01.RES.73.5.887","article-title":"Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension","volume":"73","author":"Miyauchi","year":"1993","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2019.02.007_bib93","first-page":"707","article-title":"The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells","volume":"138","author":"Reindel","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2019.02.007_bib94","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1378\/chest.104.4.1282","article-title":"Radiation-induced pulmonary veno-occlusive disease","volume":"104","author":"Kramer","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.ajpath.2019.02.007_bib95","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1034\/j.1600-6143.2002.20815.x","article-title":"A successful liver transplantation for refractory hepatic veno-occlusive disease originating from cord blood transplantation","volume":"2","author":"Kim","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajpath.2019.02.007_bib96","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1056\/NEJMoa0707064","article-title":"Use of multiple biomarkers to improve the prediction of death from cardiovascular causes","volume":"358","author":"Zethelius","year":"2008","journal-title":"N Engl J Med"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944018303201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944018303201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:06:58Z","timestamp":1762081618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944018303201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0002944018303201"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2019.02.007","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2019.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}